[go: up one dir, main page]

HK1257271A1 - 單環內酰胺抗生素的鹽和固體形式 - Google Patents

單環內酰胺抗生素的鹽和固體形式

Info

Publication number
HK1257271A1
HK1257271A1 HK18116415.3A HK18116415A HK1257271A1 HK 1257271 A1 HK1257271 A1 HK 1257271A1 HK 18116415 A HK18116415 A HK 18116415A HK 1257271 A1 HK1257271 A1 HK 1257271A1
Authority
HK
Hong Kong
Prior art keywords
salt
solid forms
lactam antibiotics
monocyclic lactam
monocyclic
Prior art date
Application number
HK18116415.3A
Other languages
English (en)
Inventor
Eric Aubin
Andreas Fisch
Michael Mutz
Bernd Ulrich Riebesehl
Marc Schoenhentz
Anthony Casarez
Zaixing Li
Mika Lindvall
Heinz Ernst Moser
Folkert Reck
Vijay Sethuraman
Robert Lowell Simmons
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1257271A1 publication Critical patent/HK1257271A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK18116415.3A 2015-09-23 2018-12-21 單環內酰胺抗生素的鹽和固體形式 HK1257271A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562222430P 2015-09-23 2015-09-23
PCT/CN2016/099482 WO2017050218A1 (en) 2015-09-23 2016-09-20 Salts and solid forms of monobactam antibiotic

Publications (1)

Publication Number Publication Date
HK1257271A1 true HK1257271A1 (zh) 2019-10-18

Family

ID=58385723

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116415.3A HK1257271A1 (zh) 2015-09-23 2018-12-21 單環內酰胺抗生素的鹽和固體形式

Country Status (27)

Country Link
US (1) US10919887B2 (zh)
EP (1) EP3353175B1 (zh)
JP (1) JP6837480B2 (zh)
KR (1) KR102749337B1 (zh)
CN (1) CN108137573B (zh)
AU (1) AU2016327264B2 (zh)
CA (1) CA2999794C (zh)
CL (2) CL2018000745A1 (zh)
CY (1) CY1123509T1 (zh)
DK (1) DK3353175T3 (zh)
EA (2) EA037569B1 (zh)
ES (1) ES2817537T3 (zh)
HK (1) HK1257271A1 (zh)
HR (1) HRP20201423T1 (zh)
HU (1) HUE050849T2 (zh)
IL (1) IL258254B (zh)
LT (1) LT3353175T (zh)
MA (1) MA42946B1 (zh)
MX (1) MX377532B (zh)
PH (1) PH12018500653B1 (zh)
PL (1) PL3353175T3 (zh)
PT (1) PT3353175T (zh)
RS (1) RS60805B1 (zh)
RU (1) RU2754180C2 (zh)
SI (1) SI3353175T1 (zh)
SM (1) SMT202000480T1 (zh)
WO (1) WO2017050218A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3661933B1 (en) 2017-08-02 2022-03-23 Novartis AG Process for preparing 1-(((z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3s,4r)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3- yl)amino)ethylidene)amino)oxy)cyclopropane carboxylic acid
US11760866B2 (en) * 2017-08-16 2023-09-19 Lg Chem, Ltd. White pigment comprising ZIF-based powder, polymer resin film and method for changing color of medium using white pigment
WO2019092180A1 (en) * 2017-11-10 2019-05-16 Novartis Ag Administration of monobactam for the treatment of urinary tract infection
CN111511737B (zh) * 2018-01-29 2022-10-18 南京明德新药研发有限公司 用于治疗细菌感染的单环β-内酰胺化合物
JP7179185B2 (ja) * 2018-12-18 2022-11-28 メッドシャイン ディスカバリー インコーポレイテッド 医薬の製造おける単環式β－ラクタム化合物の使用
US20230037556A1 (en) * 2019-11-22 2023-02-09 Suzhou Erye Pharmaceutical Co., Ltd SULFONYLUREA RING SUBSTITUTED MONOCYCLIC beta-LACTAM ANTIBIOTICS
US20230022708A1 (en) 2019-12-19 2023-01-26 Medshine Discovery Inc. Application of compound in drug preparation
CN113754651B (zh) 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
WO2022027439A1 (en) * 2020-08-06 2022-02-10 Ningxia Academy Of Agriculture And Forestry Sciences β-LACTAM COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
WO2022185241A1 (en) 2021-03-04 2022-09-09 Bp Asset Vi, Inc. Process for manufacturing a monobactam antibiotic
WO2022185240A1 (en) 2021-03-04 2022-09-09 Bp Asset Vi, Inc. Formulation of a monobactam antibiotic
CN115304594B (zh) * 2022-10-12 2023-02-14 苏州二叶制药有限公司 磺酰脲环取代的化合物的盐型及其晶型

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196202A (en) 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)
US4775670A (en) 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
EP0048953B1 (en) 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-lactam antibiotics
WO1982001873A1 (en) 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4782147A (en) 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
CA1262128A (en) 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
IL67451A (en) 1981-12-25 1987-10-20 Takeda Chemical Industries Ltd 4-cyano-2-azetidinones and production thereof and process for the preparation of 4-carbamoyl-2-azetidinones using them
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
HU189290B (en) 1982-05-31 1986-06-30 Banyu Pharmaceutical Co Ltd,Jp Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
DE3377061D1 (en) 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
JPS6153282A (ja) 1984-08-22 1986-03-17 Banyu Pharmaceut Co Ltd 単環β−ラクタム誘導体
JPS6153283A (ja) 1984-08-24 1986-03-17 Banyu Pharmaceut Co Ltd ２−オキソ−１−アゼチジンスルホン酸誘導体
US4610824A (en) 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US5112968A (en) 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
ES2602969T3 (es) 2008-10-31 2017-02-23 Shionogi & Co., Ltd. Cefalosporinas que tienen un grupo catecol
EP2379546A1 (en) 2008-12-19 2011-10-26 Pfizer Inc. Monocarbams
MX2013005994A (es) 2010-11-29 2013-07-15 Pfizer Monobactamas.
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103044416A (zh) 2012-12-17 2013-04-17 浙江华方药业有限责任公司 一种卡芦莫南钠的合成方法
WO2015103583A1 (en) 2014-01-06 2015-07-09 President And Fellows Of Harvard College Monobactams and methods of their synthesis and use
UA121383C2 (uk) * 2014-03-24 2020-05-25 Новартіс Аг Органічні сполуки, що є монобактамами, для лікування бактеріальних інфекцій

Also Published As

Publication number Publication date
SMT202000480T1 (it) 2020-11-10
PL3353175T3 (pl) 2021-02-22
RU2018114480A3 (zh) 2020-06-09
DK3353175T3 (da) 2020-09-14
CL2019003324A1 (es) 2020-04-17
ES2817537T3 (es) 2021-04-07
RU2018114480A (ru) 2019-10-23
JP6837480B2 (ja) 2021-03-03
EP3353175A4 (en) 2019-06-26
CN108137573B (zh) 2021-06-11
CY1123509T1 (el) 2022-03-24
AU2016327264B2 (en) 2019-06-27
EA201890771A1 (ru) 2018-09-28
AU2016327264A1 (en) 2018-05-10
PH12018500653B1 (en) 2022-05-04
CN108137573A (zh) 2018-06-08
MA42946B1 (fr) 2020-10-28
RU2754180C2 (ru) 2021-08-30
PH12018500653A1 (en) 2018-10-01
RS60805B1 (sr) 2020-10-30
EP3353175B1 (en) 2020-08-12
MX2018003592A (es) 2018-06-18
MA42946A (fr) 2018-08-01
JP2018528241A (ja) 2018-09-27
KR102749337B1 (ko) 2025-01-03
PT3353175T (pt) 2020-09-10
US10919887B2 (en) 2021-02-16
WO2017050218A1 (en) 2017-03-30
CA2999794C (en) 2023-08-15
EA037569B1 (ru) 2021-04-15
CL2018000745A1 (es) 2018-06-22
IL258254B (en) 2021-02-28
HRP20201423T1 (hr) 2020-12-11
MX377532B (es) 2025-03-10
EA202092620A1 (ru) 2021-06-30
LT3353175T (lt) 2020-10-12
SI3353175T1 (sl) 2020-11-30
IL258254A (en) 2018-05-31
US20180273522A1 (en) 2018-09-27
EP3353175A1 (en) 2018-08-01
CA2999794A1 (en) 2017-03-30
HUE050849T2 (hu) 2021-01-28
BR112018005805A2 (pt) 2018-10-16
KR20180054816A (ko) 2018-05-24

Similar Documents

Publication Publication Date Title
HK1257271A1 (zh) 單環內酰胺抗生素的鹽和固體形式
IL284874A (en) Valbenazine salts and polymorphs thereof
FIC20240005I1 (fi) Elasestrantti tai sen suola
IL264521A (en) Solid forms of lometaferon ditosylate
LT3302565T (lt) Kietos palbociklibo dozavimo formos
IL293377A (en) Hsd17b13 variants and uses thereof
HK1253684A1 (zh) 條件活性多肽
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
EP3442972A4 (en) BROMDOMÄNENINHIBITOREN
PT3548033T (pt) Compostos e respectivos métodos de utilização
EP3386590A4 (en) BICYCLIC INHIBITORS OF PAD4
EP3386505A4 (en) AZA-BENZIMIDAZOLINHIBITORS OF PAD4
PL3498292T3 (pl) Konstrukty białka uspa2 i ich zastosowania
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
EP3381018A4 (en) TRIGGER THE REGIONS
DK3283041T3 (da) Collagenstimuleringsanordning
IL262379A (en) Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function
HK1251225A1 (zh) 新型苯並咪唑化合物及其製藥用途
HUE053863T2 (hu) Penicillin-G acilázok
DK3672948T3 (da) Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3323485T3 (da) Krystalliseringssøjle og krystalliseringsfremgangsmåde
EP3137649C0 (en) METALLIZATION OF SURFACES
RS60939B1 (sr) Čvrsti oblici soli nilotiniba
MA42130A (fr) Combinaisons d'opioïdes et de n-acyléthanolamines